{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:23:47Z","timestamp":1784568227722,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020430","name":"LG Chem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020430","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bbrep.2024.101673","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T16:52:49Z","timestamp":1709398369000},"page":"101673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gemigliptin, a potent selective dipeptidyl peptidase 4 inhibitor, protects endothelial progenitor cells by oxidative stress via caspase-3 dependent pathway"],"prefix":"10.1016","volume":"38","author":[{"given":"Mijung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Rashid","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2024.101673_bib1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/0963689718779345","article-title":"Endothelial progenitor cells in age-related vascular remodeling","volume":"27","author":"Yang","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrep.2024.101673_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5966\/sctm.2015-0227","article-title":"Concise review: endothelial progenitor cells in regenerative medicine: applications and challenges","volume":"5","author":"Chong","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.bbrep.2024.101673_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/1574888X13666180502100620","article-title":"Endothelial progenitor cells as molecular targets in vascular senescence and repair","volume":"13","author":"Rana","year":"2018","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.bbrep.2024.101673_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12967-017-1280-y","article-title":"Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder","volume":"15","author":"Ambasta","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrep.2024.101673_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-015-0130-8","article-title":"Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy","volume":"8","author":"Li","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrep.2024.101673_bib6","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/hh1301.093953","article-title":"Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease","volume":"89","author":"Vasa","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrep.2024.101673_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrep.2024.101673_bib8","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1212\/01.wnl.0000294329.93565.94","article-title":"Decreased number and function of endothelial progenitor cells in patients with migraine","volume":"70","author":"Lee","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.bbrep.2024.101673_bib9","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3233\/JAD-2010-1315","article-title":"Dysfunctional characteristics of circulating angiogenic cells in Alzheimer's disease","volume":"19","author":"Lee","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bbrep.2024.101673_bib10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3727\/096368910X516637","article-title":"Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing","volume":"19","author":"Kim","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bbrep.2024.101673_bib11","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00125-007-0732-y","article-title":"Glucose tolerance is negatively associated with circulating progenitor cell levels","volume":"50","author":"Fadini","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrep.2024.101673_bib12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/jphp.12555","article-title":"Activation of endothelial NO synthase by a xanthine derivative ameliorates hypoxia-induced apoptosis in endothelial progenitor cells","volume":"68","author":"Wu","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbrep.2024.101673_bib13","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2147\/DMSO.S319895","article-title":"A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives","volume":"14","author":"Reed","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.bbrep.2024.101673_bib14","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s12272-013-0171-x","article-title":"Gemigliptin, a novel dipeptidyl peptidase 4 inhibitor: first new anti-diabetic drug in the history of Korean pharmaceutical industry","volume":"36","author":"Kim","year":"2013","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrep.2024.101673_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/hdi.12438","article-title":"A systematic review of the benefits and harms of dipeptidyl peptidase-4 inhibitor for chronic kidney disease","volume":"21","author":"Kamiya","year":"2017","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.bbrep.2024.101673_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4093\/dmj.2016.40.5.339","article-title":"Gemigliptin: an update of its clinical use in the management of type 2 diabetes mellitus","volume":"40","author":"Kim","year":"2016","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.bbrep.2024.101673_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrep.2024.101673_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrep.2024.101673_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI0214327","article-title":"Origin of endothelial progenitors in human postnatal bone marrow","volume":"109","author":"Reyes","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrep.2024.101673_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nprot.2007.54","article-title":"A protocol for isolation and culture of human umbilical vein endothelial cells","volume":"2","author":"Baudin","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbrep.2024.101673_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15321810601025549","article-title":"Flow-cytometric identification, enumeration, purification, and expansion of CD133+ and VEGF-R2+ endothelial progenitor cells from peripheral blood","volume":"28","author":"Rustemeyer","year":"2007","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.bbrep.2024.101673_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12015-018-9863-4","article-title":"Endothelial progenitor cells biology in diabetes mellitus and peripheral arterial disease and their therapeutic potential","volume":"15","author":"Py\u0161n\u00e1","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.bbrep.2024.101673_bib23","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","article-title":"Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization","volume":"97","author":"Kalka","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2024.101673_bib24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbrep.2024.101673_bib25","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","article-title":"Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus","volume":"45","author":"Fadini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrep.2024.101673_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1463-1326.2010.01303.x","article-title":"A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes","volume":"12","author":"Rhee","year":"2010","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.bbrep.2024.101673_bib27","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2125.2009.03376.x","article-title":"Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers","volume":"68","author":"Lim","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrep.2024.101673_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2174\/1389201019666181017161752","article-title":"Circulating endothelial progenitor cells biology and regenerative medicine in pulmonary vascular diseases","volume":"19","author":"Guerra","year":"2018","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.bbrep.2024.101673_bib29","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/stem.745","article-title":"Concise review: circulating endothelial progenitor cells for vascular medicine","volume":"29","author":"Asahara","year":"2011","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrep.2024.101673_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/bies.20372","article-title":"Endothelial progenitor cells: diagnostic and therapeutic considerations","volume":"28","author":"Liew","year":"2006","journal-title":"Bioessays"},{"key":"10.1016\/j.bbrep.2024.101673_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.jcbfm.9600509","article-title":"Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro","volume":"28","author":"Fan","year":"2008","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.bbrep.2024.101673_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/eurheartj\/ehn501","article-title":"Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair","volume":"30","author":"Matsumoto","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrep.2024.101673_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","article-title":"Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance","volume":"8","author":"Hristov","year":"2004","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrep.2024.101673_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/hh1301.092506","article-title":"Phosphatidylinositol 3-kinase\/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP)","volume":"89","author":"Suhara","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrep.2024.101673_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-016-0408-3","article-title":"Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice","volume":"15","author":"Yu","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrep.2024.101673_bib36","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbrep.2024.101673_bib37","first-page":"1015","article-title":"[Effect of simvastatin on the amount and function of endothelial progenitor cells from bone marrow in diabetic rats]","volume":"48","author":"Zhang","year":"2012","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"10.1016\/j.bbrep.2024.101673_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1358863X10367537","article-title":"Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes","volume":"15","author":"Liao","year":"2010","journal-title":"Vasc. Med."},{"key":"10.1016\/j.bbrep.2024.101673_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00125-009-1401-0","article-title":"Circulating endothelial progenitor cells, endothelial function, carotid intima\u2013media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria","volume":"52","author":"Sibal","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrep.2024.101673_bib40","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00125-012-2590-5","article-title":"Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers","volume":"55","author":"Van Ark","year":"2012","journal-title":"Diabetologia"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T22:00:20Z","timestamp":1719007220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580824000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"alternative-id":["S2405580824000372"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101673","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemigliptin, a potent selective dipeptidyl peptidase 4 inhibitor, protects endothelial progenitor cells by oxidative stress via caspase-3 dependent pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101673"}}